Link: https://mind-foundation.org/donate
-----------------------

Charles Raison, MD, is the Mary Sue and Mike Shannon Chair for Healthy Minds, Children & Families and Professor, School of Human Ecology, and Professor, Department of Psychiatry, School of Medicine and Public Health, University of Wisconsin-Madison in Madison, WI. Dr. Raison also serves as Director of Clinical and Translational Research for Usona Institute and as Director of Research on Spiritual Health for Emory Healthcare in Atlanta, GA. In addition, Dr. Raison has served as mental health expert for CNN.com for many years. Dr. Raison is internationally recognized for his studies examining novel mechanisms involved in the development and treatment of major depression and other stress-related emotional and physical conditions, as well as for his work examining the physical and behavioral effects of compassion training. More recently, Dr. Raison has taken a leadership role in the development of psychedelic medicines as potential treatments for major depression. The recipient of several teaching awards, Dr. Raison has received research funding from the National Institute of Mental Health, National Center for Complementary and Alternative Medicine, and the Centers for Disease Control and Prevention. Dr. Raison received the Raymond Pearl Memorial Award from the Human Biology Association “in recognition of his contributions to our understanding of evolutionary biocultural origins of mental health and illness.” With Vladimir Maletic he is author of “The New Mind-Body Science of Depression” published by W.W. Norton in 2017. Dr. Raison serves on the Scientific Advisory Board for the American Foundation for Suicide Prevention.

" />
Like0000000or copy the linkMD Charles L. Raison | Director of Clinical and Translational Research, Usona Institute https://insight-conference.eu/speaker/charles-l-raison/ A new approach to treating depression; a non-profit’s role in advancing the science and regulatory path to approval [More]
Like0000000or copy the linkUsing psychedelics to treat depression and trauma has just become legal in Australia. Offering hope to many, it’s not without risk. While many report life-changing benefits, others do not, and many scientists [More]
Like0000000or copy the linkSome psychoactive substances, previously banned from medical research, are now proven able to provide a credible cure for clinical depression– a real reconnection to health, to the good in you and in [More]
Like0000000or copy the linkFull Story: https://www.krqe.com/news/albuquerque-metro/unm-health-sciences-researching-psychedelics-as-treatment-for-forms-of-depression
Like0000000or copy the linkIn the three-part series “Psychedelic Renaissance,” CBS News contributor Lisa Ling explores the natural psychedelic therapies that people are experimenting with to cope with anxiety, PTSD and depression. Ling spoke to a [More]
Like0000000or copy the linkCybin experts, Dr. Alex Belser and Dr. Amir Inamdar meet again to discuss how psychedelic therapy is changing the therapeutic landscape of major depression. Learn the history of psychedelics, opportunities in treating [More]
Like0000000or copy the linkPsilocybin is a compound found in mushrooms that has psychedelic properties. Psychedelic means it makes you hallucinate. Psilocybin works in the brain by activating the 5-HT2A receptor on the neuron to increase [More]
Like0000000or copy the linkPsychedelics have re-emerged in the world of medicine as a promising treatment for post traumatic stress disorder (PTSD), depression, substance use disorder (SUD), obsessive-compulsive disorder (OCD), headaches, chronic pain, and other conditions. [More]